Completed NA INTERVENTIONAL 2-arm NCT01647191

Reducing Hepatitis C Virus (HCV)/Human Immunodeficient Virus (HIV) Risk Behaviors Among Injection Drug Users in China

Sponsor: Shanghai Mental Health Center

Interventions control group intervention group

Updated 6 times since 2017 Last updated: Jan 8, 2020 Started: Jul 1, 2011 Primary completion: May 1, 2015 Completion: May 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01647191, this NA trial focuses on Hepatitis C and remains completed. Sponsored by Shanghai Mental Health Center, it has been updated 6 times since 2011, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Feb 2020 — Jan 2021 [monthly]

Completed NA

Status: Unknown Status → Completed
Jun 2018 — Feb 2020 [monthly]

Unknown Status NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Jul 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shanghai Mental Health Center

Data source: Shanghai Mental Health Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China